A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 240

Authors :: Jia Li
S. Wang
X.-F. Chen
Qing Xie
Jifang Sheng
Qin Ning
C.-D. Jing
Q. Mao
J.-H. Xu
Hong Tang
Z.-N. Xu
Yanyan Yu
Z. Zeng
Dake Zhang
Guangfeng Shi
X.-Y. Chen
X.-Q. Zhang
J. Dai
C.-W. Si
Source :: Journal of Hepatology. 68:S517-S518
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Double blind
medicine.medical_specialty
Hepatology
Multicenter study
Chronic hepatitis
business.industry
Internal medicine
Genotype
medicine
Entecavir
business
Gastroenterology
medicine.drug

Tools